SCIENTIFIC VALIDATION OF SOME NEPALESE MEDICINAL PLANTS FROM NANGLE BHARE OF KATHMANDU, NEPAL

Journal Title: Asian Journal of Pharamceutical and Clinical Research - Year 2019, Vol 12, Issue 2

Abstract

Objective: The present study was designed to provide scientific support for the medicinal properties of traditionally used medicinal plants of Nangle Bhare, Kathmandu, Nepal. Methods: Plant extracts were prepared by cold percolation method using methanol solvent. Analysis of phytochemical constituents was carried out using standard methods. The brine shrimp toxicity assay for each extract was carried out according to Mayer et al. The 1, 1-diphenyl-2-picrylhyrazyl (DPPH) and ferric reducing antioxidant power (FRAP) assay were used to evaluate in vitro antioxidants activities. The antimicrobial activity of the plant extracts was carried by the disc diffusion method. Results: Phytochemical analysis revealed the availability of secondary metabolites such as reducing compounds, glycosides, and flavonoids in the methanolic extract of eight plants, namely, frond of Cheilanthes farinosa, leaves of Lyonia ovalifolia, leaves and roots of Rumex nepalensis, aerial stem of Equisetum debile, roots of Coix lacrema-jobi, leaves of Justica adhatoda, leaves of Osyris wightiana, and roots of Rubus ellipticus collected from Nangle Bhare village of Kathmandu district. The brine shrimp bioassay revealed that roots and leaves of R. nepalensis only exhibited lethality against brine shrimp. Frond of C. farinosa and roots of R. nepalensis exhibited good antimicrobial activity against Staphylococcus aureus and Escherichia coli. Both DPPH and FRAP assays showed that among the plant under study, R. ellipticus has lower inhibitory concentration IC50 values than other plants such as L. ovalifolia, R. nepalensis, and C. farinose. Conclusions: On the basis of this study, it was found that scientifically only four, namely C. farinosa, L. ovalifolia, R. nepalensis, and R. ellipticus have medicinal potentials.

Authors and Affiliations

BIMALA SUBBA, MAHESH PRASAD TIMILSINA

Keywords

Related Articles

NANOSTRUCTURE LIPID CARRIERS: A PROMISING TOOL FOR THE DRUG DELIVERY IN THE TREATMENT OF SKIN CANCERNANOSTRUCTURE LIPID CARRIERS: A PROMISING TOOL FOR THE DRUG DELIVERY IN THE TREATMENT OF SKIN CANCER

Skin cancer is the most common type of cancer having a very high rate of incidence, exceeding the sum of all other types of cancers. Current topical treatments for non-melanoma skin cancer and their precursor lesions, su...

HYDROALCOHOLIC EXTRACT OF MATRICARIA CHAMOMILLA LINN. AMELIORATES LIPIDS, LIPOPROTEINS, AND PARAOXONASE IN ISOPROTERENOL-INDUCED MYOCARDIAL INFARCTION IN WISTAR RATS

Objective: The objective of this study was to evaluate the effect of the hydroalcoholic extract of Matricaria Chamomilla Linn. (CHAE) on lipids, lipoproteins, and antioxidants activity in isoproterenol (ISO)-induced myoc...

A REVIEW ON SCREENING METHODS OF BREAST CANCER, CANCER BIOMARKERS AND PHYTOCONSTITUENTS AGAINST BREAST CANCER

  A cancer biomarker refers to a substance or process that is used as an indicative the presence of cancer in the body. A biomarker may be a molecule secreted by a tumor or a specific response of the body to the presen...

THE ROLE OF SELENIUM MICRONUTRIENTS AS ANTIOXIDANTS IN EXPOSURE TO E-CIGARETTE SMOKE

Objective: E-cigarette products have resulted in various controversies concerning their posed impacts on health. Some argue that exposure to e-cigarette smoke could improve free radicals in the body; thus, it causes harm...

EFFECT OF YOHIMBINE ON CLOMIPRAMINE-INDUCED SEXUAL DYSFUNCTION IN MALE RATS

Object: The present investigation has been carried out to find out the effect of yohimbine on clomipramine-induced sexual dysfunction in male rats.Methods: The male rats were treated with clomipramine and yohimbine simul...

Download PDF file
  • EP ID EP608762
  • DOI -
  • Views 108
  • Downloads 0

How To Cite

BIMALA SUBBA, MAHESH PRASAD TIMILSINA (2019). SCIENTIFIC VALIDATION OF SOME NEPALESE MEDICINAL PLANTS FROM NANGLE BHARE OF KATHMANDU, NEPAL. Asian Journal of Pharamceutical and Clinical Research, 12(2), 205-209. https://europub.co.uk/articles/-A-608762